Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.72m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Acquisition

7 Sep 2009 07:00

RNS Number : 5982Y
Merchant Securities PLC
07 September 2009
 



News release

7 September 2009

Merchant Securities plc

Acquisition of Wealth Management Company

Merchant Securities plc (the "Group"), the financial services group specialising in private client investment management, institutional research and trading, corporate finance and corporate broking announces that it has entered into an unconditional agreement (the "Agreement") to acquire Cavendish Young Limited,  ("Cavendish Young") an Independent Financial Adviser & fee based Wealth Management  company based in Belgravia, London (the "Acquisition").

Cavendish Young, which was formed in 1999, manages £46 million for high net worth individuals and has a total client base of 2500 private clientsFor the year ended 31 March 2009, Cavendish Young made a profit before taxation of £2,665 on turnover of £630,342 and had net assets of £229,018 on that date. The sellers of Cavendish Young are Mark Estcourt, the founder and managing director of the company and his wife Tracy Estcourt. Mr Estcourt has entered into a new service agreement with Cavendish Young. 

The initial consideration for the Acquisition is £65,000, of which £32,500 was paid on completion, with the balance payable following agreement of the completion balance sheet. Further deferred consideration may become payable dependent upon two factors: the future profitability of Cavendish Young in the financial periods ending 31 March 2014, with a potential deferred consideration in this regard capped at £800,000 and the amount of funds which come under the discretionary management of the Group over the same period, with an additional potential deferred consideration capped at £500,000, giving a maximum potential total consideration of £1.3 million

As at 31 July 2009 the Group had £85 million under advisory management and a further £6.5 million under discretionary management. The Acquisition increases the total funds under Group management to over £135 million and has the potential to increase the funds under the Group's discretionary management to over £50 million, before any future growth.

Patrick Claridge, Chief Executive of Merchant Securities plc, says:

"This acquisition fits well with our strategy to increase long term recurring income across our three sectors of private client, institutional and corporate finance and corporate broking businessThis deal represents a major step forward for the private client businessincreasing total Group funds under advisory and discretionary management to over £135 million. We will continue to seek appropriate ways of expanding the Group, with an emphasis on increasing long term recurring income and delivering a high-quality service to our entire client base."

- Ends - 

For further information please contact:

Merchant Securities plc

Patrick Claridge (Chief Executive)

Broadgate

Roland Cross/Emma Murphy

Arden Partners plc

Richard Day

020 7375 9010

020 7726 6111

020 7398 1600

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLIMRTMMIMBIL
Date   Source Headline
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million
2nd Apr 20207:00 amRNSPortfolio companies collaborate against COVID-19
27th Mar 202011:30 amRNSDirector/PDMR Dealings
25th Mar 20203:08 pmRNSCOVID-19 Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.